World Healthcare Report
SEE OTHER BRANDS

Keeping up with healthcare and wellness news from the world

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on World Healthcare Report.

PetVivo and Commonwealth Partner to Advance Equine Wellness Across Thoroughbred Racing

PetVivo and Commonwealth Partner to Advance Equine Wellness Across Thoroughbred Racing

Minneapolis, MN, June 06, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), an emerging biomedical device company focused on animal health, today announced a strategic collaboration with Commonwealth, the syndicated...

NextGen Healthcare Welcomes Madison Dearborn Partners as New Investment Partner and Announces Planned Leadership Succession

NextGen Healthcare Welcomes Madison Dearborn Partners as New Investment Partner and Announces Planned Leadership Succession

NextGen Healthcare, Inc. (“NextGen Healthcare” or the “Company”), a leading provider of innovative, cloud-based healthcare technology solutions, today announced that funds affiliated with Madison Dearborn Partners, LLC (“MDP”), a leading private...

TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the Goldman Sachs 46th Annual Global Healthcare...

Huntington’s Disease: Charting a New Path with Disease-Modifying Therapies and Strategic Innovation

Huntington’s Disease: Charting a New Path with Disease-Modifying Therapies and Strategic Innovation

The Huntington’s disease treatment market is evolving, with novel therapies targeting mHTT and reshaping the future of neurodegeneration. AUSTIN, TX, UNITED STATES, June 6, 2025 /⁨EINPresswire.com⁩/ -- Disease Overview Huntington's disease (HD) is...

Hospital ECAT Win Enables Lovell to Broaden Access to Critical Equipment Across VA and DoD

Hospital ECAT Win Enables Lovell to Broaden Access to Critical Equipment Across VA and DoD

Lovell Government Services wins ECAT PENSACOLA, FL, UNITED STATES, June 4, 2025 /⁨EINPresswire.com⁩/ -- Lovell Government Services (Lovell), a Service-Disabled Veteran-Owned Small Business (SDVOSB), has been awarded a Hospital ECAT (Electronic...

AG Yost’s Statement on Insight’s Reopening of Trumbull Regional Medical Center and Hillside Rehabilitation Hospital

AG Yost’s Statement on Insight’s Reopening of Trumbull Regional Medical Center and Hillside Rehabilitation Hospital

(WARREN, Ohio) — Ohio Attorney General Dave Yost met with Insight Health System on Tuesday, June 3 to discuss their plan to reopen Trumbull Regional Medical Center and Hillside Rehabilitation Hospital. He issued the following statement in support...

Clinical Laboratory Molecular Diagnostics for Infectious Disease Markets 2025-2029: Strategies, Trends, and Forecasts by Application, Place and Country with Market Analysis & Executive Guides - ResearchAndMarkets.com

Clinical Laboratory Molecular Diagnostics for Infectious Disease Markets 2025-2029: Strategies, Trends, and Forecasts by Application, Place and Country with Market Analysis & Executive Guides - ResearchAndMarkets.com

The "Clinical Laboratory Molecular Diagnostics for Infectious Disease Markets 2025-2029: Strategies, Trends, and Forecasts by Application, Place and Country with Market Analysis & Executive Guides" report has been added to ResearchAndMarkets.com's...

WorkCare Names Aaron Atkinson as Chief Executive Officer

WorkCare Names Aaron Atkinson as Chief Executive Officer

New CEO to Drive Innovation, Technology Adoption, and Strategic Growth in Occupational Health ANAHEIM, CA, UNITED STATES, June 10, 2025 /⁨EINPresswire.com⁩/ -- WorkCare, Inc., a leading U.S.-based occupational health company, today announced the...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Treace Medical Concepts, Inc. (“Treace Medical” or the “Company”) (NASDAQ: TMCI). Such investors are advised to contact Danielle Peyton at...

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Treace Medical To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Treace Medical between...

Dr. Erik Brecelj on the GOVSI Podcast: "I want to live in a country where healthcare is accessible to everyone"

Dr. Erik Brecelj on the GOVSI Podcast: "I want to live in a country where healthcare is accessible to everyone"

SLOVENIA, June 5 - In the 22nd episode of the Gov.si podcast, produced by the Slovenian Government Communication Office, host Petra Bezjak Cirman welcomed Dr. Erik Brecelj, a surgeon at the Institute of Oncology Ljubljana and Chair of the...

Quanterix to Present at Goldman Sachs Global Healthcare Conference

Quanterix to Present at Goldman Sachs Global Healthcare Conference

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that President and Chief Executive Officer Masoud Toloue will present at the Goldman Sachs 46th Annual Global...

Backing the Future of Global Biotech: Reynold Lemkins’ Strategy Across Borders and Stages

Backing the Future of Global Biotech: Reynold Lemkins’ Strategy Across Borders and Stages

Reynold Lemkins Group, an international investment firm focused on value-driven cross-border capital deployment, announced the continued advancement of its strategic focus in late-stage healthcare, AI-powered therapeutics, and Asia-centered...

BESLER renews HFMA Peer Review designation

BESLER renews HFMA Peer Review designation

CHICAGO, June 10, 2025 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) today announced that, following rigorous review, BESLER has once again achieved the Peer Reviewed by HFMA® designation for its Revenue Integrity...

ELV INVESTOR NOTICE: Elevance Health, Inc. Investors with Losses are Notified of the Ongoing Securities Fraud Class Action and July 11 Deadline – BFA Law (NYSE:ELV)

ELV INVESTOR NOTICE: Elevance Health, Inc. Investors with Losses are Notified of the Ongoing Securities Fraud Class Action and July 11 Deadline – BFA Law (NYSE:ELV)

NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE: ELV) and certain of the Company’s senior executives for potential...

2025 Best of Alabama Regional Award Goes to Cancer Wellness Foundation of Central Alabama

2025 Best of Alabama Regional Award Goes to Cancer Wellness Foundation of Central Alabama

MONTGOMERY, AL, UNITED STATES, June 6, 2025 /⁨EINPresswire.com⁩/ -- The Cancer Wellness Foundation of Central Alabama (CWF) has been named a 2025 Best of Alabama Regional Award winner, recognized for its hands-on support of cancer patients who are...

ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform

ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform

UNIONDALE, NY, June 06, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today announced the formation of its Clinical Science Advisory...

OS Therapies Submits Request for Regenerative Medicine Advanced Therapy (RMAT) Designation to U.S. FDA for OST-HER2 in the Prevention of Metastases in Recurrent, Fully-Resected, Lung Metastatic Pediatric Osteosarcoma

OS Therapies Submits Request for Regenerative Medicine Advanced Therapy (RMAT) Designation to U.S. FDA for OST-HER2 in the Prevention of Metastases in Recurrent, Fully-Resected, Lung Metastatic Pediatric Osteosarcoma

OS Therapies Inc. (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today announced it has submitted a request for Regenerative Medicine Advanced Therapy...

Denovo Biopharma Announces Formation of Neuroscience Scientific Advisory Board to Advance Precision Medicine in Depression

Denovo Biopharma Announces Formation of Neuroscience Scientific Advisory Board to Advance Precision Medicine in Depression

- Scientific Advisory Board brings together distinguished experts in neuroscience to support Denovo’s CNS development programs, including the Phase 3-ready lead program, biomarker-guided DB104 (liafensine) in treatment-resistant depression (TRD) -...

Beyond Sanitizers: The Hidden Role of Enzymatic Cleaners in the Industrial & Institutional Hand Hygiene Chemicals Market

Beyond Sanitizers: The Hidden Role of Enzymatic Cleaners in the Industrial & Institutional Hand Hygiene Chemicals Market

Hand hygiene chemicals are revolutionizing industrial sanitation with biofilm-targeting, skin-friendly, and eco-safe alternatives to traditional sanitizers. NEWARK, DE, UNITED STATES, June 10, 2025 /⁨EINPresswire.com⁩/ -- The global Industrial and...

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service